Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies.
Nurudeen A AdegokeTuba N GideYizhe MaoCamelia QuekEllis PatrickMatteo S CarlinoSerigne N LôAlexander Maxwell MenziesInes Pires daSilvaIsmael A VergaraGeorgina V LongRichard A ScolyerJames S WilmottPublished in: Journal for immunotherapy of cancer (2023)
Our study provides an automatic TME classification method that may predict the clinical efficacy of immunotherapy for patients with metastatic melanoma.